نتایج جستجو برای: a9 everolimus stents drug
تعداد نتایج: 602739 فیلتر نتایج به سال:
BACKGROUND The performance of everolimus-eluting bioresorbable vascular scaffold (BVS) versus drug-eluting metallic stent (DES) in the same individual receiving multilesion percutaneous coronary intervention (PCI) remains poorly studied. This report investigates the intraindividual performance of BVS and DES in patients receiving multilesion PCI and follow-up angiography. METHODS AND RESULTS ...
BACKGROUND Second-generation everolimus-eluting stents (EES) and third generation biolimus-eluting stents (BES) have been shown to be superior to first-generation paclitaxel-eluting stents (PES) and second-generation sirolimus-eluting stents (SES). However, neointimal proliferation and very late stent thrombosis is still an unresolved issue of drug-eluting stent (DES) implantation overall. The ...
1. Impact of technique on early and late outcomes following coronary Bioresorbable scaffold implantation: Analysis from the ABSORB trials . . . . . 304 2. Two-year clinical outcomes of the ABSORB BVS compared EES: A propensity matched analysis of the BVS expand registry . . . . . . . . . . . . 305 3. Transcatheter aortic valve replacement using the Lotus valve with Depth Guard: First report fro...
INTRODUCTION The issue of whether various drug-eluting stents (DES) provide similar benefit in diabetic patients with coronary artery disease remains unclear. The purpose of the study is to assess the clinical utility of the second-generation and first-generation DES in patients with diabetes mellitus by a meta-analysis. MATERIAL AND METHODS A systematic literature search of PubMed, EMBASE, a...
OBJECTIVES The study evaluated serial quantitative and qualitative changes in vascular responses to drug-eluting stents (DES) using optical coherence tomography (OCT). BACKGROUND Serial changes in stent strut coverage and neointima characteristics in DES-treated lesions have not been sufficiently investigated using OCT. METHODS Serial OCT was performed in 72 patients with 76 DES-treated les...
BACKGROUND Stent edge restenosis (SER) remains a potential limitation of drug-eluting stents. The aim of this study was to determine optical coherence tomography (OCT) predictors for angiographic late SER after everolimus-eluting stent implantation. METHODS AND RESULTS We retrospectively analyzed 319 patients who underwent OCT immediately after everolimus-eluting stent implantation and schedu...
Despite the remarkable benefits obtained following the introduction of the first-generation drug-eluting stent (DES), concerns were raised over its long-term safety, particularly with regard to very late (beyond 1 year) stent thrombosis. Newer-generation DESs have been developed to overcome this limitation using novel stent platforms, new drugs, more biocompatible durable polymers, and bioabsor...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید